Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by diuretic use: A FIDELITY analysis

被引：0
|
作者：
Mentz, R. [1 ]
Anker, S. [2 ]
Pitt, B. [3 ]
Rossing, P. [4 ]
Ruilope, L. [5 ,6 ]
Gebel, M. [7 ]
Kolkhof, P. [8 ]
Lawatscheck, R. [9 ]
Rohwedder, K. [10 ]
Bakris, G. [11 ]
机构：
[1] Duke Univ, Sch Med, Durham, NC USA
[2] Charite Univ Med Berlin, Dept Cardiol CVK, German Heart Ctr Charite, Berlin, Germany
[3] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA
[4] Steno Diabet Ctr, Herlev, Denmark
[5] Inst Res Imas12, Cardiorenal Translat Lab, Madrid, Spain
[6] Inst Res Imas12, Hypertens Unit, Madrid, Spain
[7] Bayer AG, Stat & Data Insights, Wuppertal, Germany
[8] Bayer AG, Res & Early Dev, Wuppertal, Germany
[9] Bayer AG, Clin Res, Wuppertal, Germany
[10] Bayer AG, Med Affairs, Wuppertal, Germany
[11] Univ Chicago Med, Dept Med, Chicago, IL USA
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Long-term cardiorenal efficacy of finerenone in patients with chronic kidney disease and type 2 diabetes
    Qiu, Mei
    Zhao, Li-Min
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (10) : 11239 - 11241
  • [22] Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Filippatos, Gerasimos
    Anker, Stefan D.
    Agarwal, Rajiv
    Pitt, Bertram
    Rossing, Peter
    Ruilope, Luis M.
    Kolkhof, Peter
    Schloemer, Patrick
    Tornus, Ingo
    Joseph, Amer
    Bakris, George L.
    CIRCULATION, 2020, 142 (24) : E470 - E470
  • [23] Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Filippatos, Gerasimos
    Anker, Stefan D.
    Agarwal, Rajiv
    Pitt, Bertram
    Ruilope, Luis M.
    Rossing, Peter
    Kolkhof, Peter
    Schloemer, Patrick
    Tornus, Ingo
    Joseph, Amer
    Bakris, George L.
    CIRCULATION, 2021, 143 (06) : 540 - 552
  • [24] Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes
    Moura-Neto, Jose A.
    Ronco, Claudio
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (11):
  • [25] Bringing FIDELITY to the estimate of treatment effects of finerenone in chronic kidney disease due to type 2 diabetes
    Adamson, Carly
    Jhund, Pardeep S.
    EUROPEAN HEART JOURNAL, 2022, 43 (06) : 485 - 487
  • [26] Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis (vol 43, pg 474, 2022)
    Agarwal, Rajiv
    Filippatos, Gerasimos
    Pitt, Bertram
    Anker, Stefan D.
    Rossing, Peter
    Joseph, Amer
    Kolkhof, Peter
    Nowack, Christina
    Gebel, Martin
    Ruilop, Luis M.
    Bakris, George L.
    EUROPEAN HEART JOURNAL, 2022, 43 (20) : 1989 - 1989
  • [27] The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study
    Rossing, Peter
    Anker, Stefan D. D.
    Filippatos, Gerasimos
    Pitt, Bertram
    Ruilope, Luis M. M.
    Billings, Liana K. K.
    Green, Jennifer B. B.
    Koya, Daisuke
    Mosenzon, Ofri
    Pantalone, Kevin M. M.
    Ahlers, Christiane
    Lage, Andrea
    Lawatscheck, Robert
    Scalise, Andrea
    Bakris, George L. L.
    DIABETES OBESITY & METABOLISM, 2023, 25 (10): : 2989 - 2998
  • [28] Efficacy and safety of finerenone in patients with CKD and type 2 diabetes across the frailty spectrum: a FIDELITY post hoc analysis
    Rossing, P.
    Birkenfeld, A.
    Fioretto, P.
    McGill, J. B.
    Anker, S. D.
    Pitt, B.
    Scalise, A.
    Scott, C.
    Filippatos, G.
    DIABETOLOGIA, 2024, 67 : S426 - S427
  • [29] Finerenone (Kerendia) for the Treatment of Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus
    Stewart-Lynch, Autumn
    AMERICAN FAMILY PHYSICIAN, 2023, 108 (03) : 305 - 306
  • [30] Optimization of potassium management in patients with chronic kidney disease and type 2 diabetes on finerenone
    Ortiz, Alberto
    Arroyo, Roberto Alcazar
    Escribano, Pedro Pablo Casado
    Fernandez-Fernandez, Beatriz
    Deben, Francisco Martinez
    Mediavilla, Juan Diego
    Michan-Dona, Alfredo
    Soler, Maria Jose
    Gorriz, Jose Luis
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (06) : 519 - 531
12345